| Fairmount Funds Management Llc |
Non-Executive Director |
Zenas BioPharma, Inc. (ZBIO)
|
2024-09-16 |
$17.00 |
0.0% |
300,000
|
$5,100,000 |
| Fairmount Funds Management Llc |
Non-Executive Director |
Viridian Therapeutics, Inc.\DE (VRDN)
|
2024-09-13 |
$18.75 |
0.0% |
1,600,000
|
$30,000,000 |
| Fairmount Funds Management Llc |
Non-Executive Director |
Viridian Therapeutics, Inc.\DE (VRDN)
|
2024-01-22 |
$21.00 |
-35.9% |
476,190
|
$9,999,990 |
| Fairmount Funds Management Llc |
Non-Executive Director |
Dianthus Therapeutics, Inc. /DE/ (DNTH)
|
2023-09-29 |
$13.63 |
105.3% |
24,670
|
$336,252 |
| Fairmount Funds Management Llc |
Non-Executive Director |
Dianthus Therapeutics, Inc. /DE/ (DNTH)
|
2023-09-26 |
$13.15 |
112.8% |
30,000
|
$394,500 |
| Fairmount Funds Management Llc |
Non-Executive Director |
Dianthus Therapeutics, Inc. /DE/ (DNTH)
|
2023-09-19 |
$13.20 |
112.0% |
30,000
|
$396,000 |
| Fairmount Funds Management Llc |
Non-Executive Director |
Dianthus Therapeutics, Inc. /DE/ (DNTH)
|
2023-09-13 |
$11.20 |
149.8% |
24,254
|
$271,680 |
| Fairmount Funds Management Llc |
Non-Executive Director |
Apogee Therapeutics, Inc. (APGE)
|
2023-07-13 |
$17.00 |
183.8% |
2,941,176
|
$49,999,992 |
| Fairmount Funds Management Llc |
Non-Executive |
Cogent Biosciences, Inc. (COGT)
|
2023-06-09 |
$12.00 |
-6.3% |
800,000
|
$9,600,000 |
| Fairmount Funds Management Llc |
Non-Executive Director |
Viridian Therapeutics, Inc.\DE (VRDN)
|
2022-08-17 |
$23.50 |
-42.7% |
425,531
|
$9,999,978 |
| Fairmount Funds Management Llc |
Non-Executive |
Cogent Biosciences, Inc. (COGT)
|
2022-06-16 |
$8.25 |
36.2% |
1,200,000
|
$9,900,000 |
| Fairmount Funds Management Llc |
Non-Executive Director |
Viridian Therapeutics, Inc.\DE (VRDN)
|
2021-09-21 |
$11.00 |
22.5% |
909,000
|
$9,999,000 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
66.8% |
$90,903,049 |
$135,997,392 |